Orexo Ab Stock Performance
| ORXOF Stock | USD 3.23 0.00 0.00% |
Orexo AB has a performance score of 10 on a scale of 0 to 100. The company holds a Beta of -0.015, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Orexo AB are expected to decrease at a much lower rate. During the bear market, Orexo AB is likely to outperform the market. Orexo AB right now holds a risk of 0.74%. Please check Orexo AB coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Orexo AB will be following its historical price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Orexo AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Orexo AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 505.3 M | |
| Total Cashflows From Investing Activities | -52.9 M | |
| Free Cash Flow | -281.8 M |
Orexo |
Orexo AB Relative Risk vs. Return Landscape
If you would invest 305.00 in Orexo AB on November 4, 2025 and sell it today you would earn a total of 18.00 from holding Orexo AB or generate 5.9% return on investment over 90 days. Orexo AB is currently producing 0.0937% returns and takes up 0.7435% volatility of returns over 90 trading days. Put another way, 6% of traded otc stocks are less volatile than Orexo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Orexo AB Target Price Odds to finish over Current Price
The tendency of Orexo OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.23 | 90 days | 3.23 | about 10.38 |
Based on a normal probability distribution, the odds of Orexo AB to move above the current price in 90 days from now is about 10.38 (This Orexo AB probability density function shows the probability of Orexo OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Orexo AB has a beta of -0.015. This indicates as returns on the benchmark increase, returns on holding Orexo AB are expected to decrease at a much lower rate. During a bear market, however, Orexo AB is likely to outperform the market. Additionally Orexo AB has an alpha of 0.0799, implying that it can generate a 0.0799 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Orexo AB Price Density |
| Price |
Predictive Modules for Orexo AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orexo AB. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Orexo AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orexo AB is not an exception. The market had few large corrections towards the Orexo AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orexo AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orexo AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | -0.01 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | 0.06 |
Orexo AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orexo AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orexo AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the revenue of 565 M. Net Loss for the year was (223.5 M) with profit before overhead, payroll, taxes, and interest of 521.7 M. | |
| Orexo AB has accumulated about 45.61 M in cash with (229 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Orexo AB Fundamentals Growth
Orexo OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Orexo AB, and Orexo AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Orexo OTC Stock performance.
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0965 | |||
| Profit Margin | (0.28) % | |||
| Current Valuation | 76.98 M | |||
| Shares Outstanding | 34.35 M | |||
| Price To Earning | 58.66 X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 0.99 X | |||
| Revenue | 565 M | |||
| EBITDA | (141.3 M) | |||
| Cash And Equivalents | 45.61 M | |||
| Cash Per Share | 1.32 X | |||
| Total Debt | 492.3 M | |||
| Debt To Equity | 1.76 % | |||
| Book Value Per Share | 1.07 X | |||
| Cash Flow From Operations | (229 M) | |||
| Total Asset | 1.27 B | |||
| Current Asset | 907 M | |||
| Current Liabilities | 303 M | |||
About Orexo AB Performance
By analyzing Orexo AB's fundamental ratios, stakeholders can gain valuable insights into Orexo AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Orexo AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Orexo AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.Things to note about Orexo AB performance evaluation
Checking the ongoing alerts about Orexo AB for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Orexo AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 565 M. Net Loss for the year was (223.5 M) with profit before overhead, payroll, taxes, and interest of 521.7 M. | |
| Orexo AB has accumulated about 45.61 M in cash with (229 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Orexo AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Orexo AB's stock is overvalued or undervalued compared to its peers.
- Examining Orexo AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Orexo AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Orexo AB's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Orexo AB's otc stock. These opinions can provide insight into Orexo AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Orexo OTC Stock analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |